Skip to main content
ACHIEVE LIFE SCIENCES, INC. logo

ACHIEVE LIFE SCIENCES, INC. — Investor Relations & Filings

Ticker · ACHV ISIN · US0044685008 LEI · 549300V82ZKZDTAU0A46 US Manufacturing
Open in API
Filings indexed 1,014 across all filing types
Latest filing 2008-12-23 Major Shareholding Noti…
Country US United States of America
Listing US ACHV

About ACHIEVE LIFE SCIENCES, INC.

https://achievelifesciences.com/

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company dedicated to addressing the global nicotine dependence epidemic. The company's primary focus is the development and commercialization of its lead product candidate, cytisinicline, for smoking cessation. Following the successful completion of two Phase 3 studies, the company submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA), which has been accepted for review. If approved, cytisinicline has the potential to become the first new FDA-approved treatment option for nicotine dependence in the United States in nearly two decades.

Recent filings

Filing Released Lang Actions
SCHEDULE 13D - AMENDMENT #1 (ONCOGENEX)
Major Shareholding Notification
2008-12-23 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed by OncoGenex Pharmaceuticals, Inc. dated December 18, 2008. It reports a temporary suspension of trading under the company's employee benefit plans due to amendments to the 401(k) Profit Sharing Plan and the resulting blackout period. The document includes a notice to directors and executive officers about the blackout period and references compliance with the Sarbanes-Oxley Act and Securities Exchange Act. There are no financial statements or substantive financial data presented, nor is this a full annual or quarterly report. The document is a regulatory announcement about a specific event affecting the company's employee benefit plan and trading restrictions during the blackout period. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement since it contains substantive information about the blackout period. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2008-12-18 English
AMENDMENT NO. 1
Major Shareholding Notification
2008-12-16 English
Director's Dealing 2008
Director's Dealing
2008-12-16 English
Regulatory Filings 2008
Regulatory Filings
2008-12-09 English
Regulatory Filings 2008
Regulatory Filings
2008-12-09 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.